SOPH: SOPHiA Genetics SA Company Profile & Statistics

About

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.

Info & Links

CEO

Jurgi Camblong

Headquarters

LA PIECE, CH-1180
ROLLE, V8 , SWITZERLAND

Auditor

PricewaterhouseCoopers SA

Share holders

Employees

449

SOPHiA Genetics SA Statistics

Valuation Measures

Market Capitalization²

209.87M

Enterprise Value

127.24M

Enterprise Value/EBITDA(ttm)

-2.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.33

Price to Book(mrq)

1.89

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

67.78%

Operating Margin(ttm)

-110.71%

Profit Margin(ttm)

-110.10%

Return on Equity(ttm)

-55.06%

Return on Invested Capital(ttm)

-52.08%

Return on Assets(ttm)

-38.33%

Income Statement

Revenue(ttm)

64.49M

Revenue Per Share(ttm)

Gross Profit(ttm)

43.73M

EBITDA(ttm)³

-59.78M

Net Income Available to Common(ttm)

-71.40M

Diluted EPS(ttm)

-1.09

Share Statistics

Beta (5Y Monthly)

0.99

52-Week Change

-22.65%

S&P 500 52-Week Change

26.10%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

62.19M

% Held by Insiders

4.88%

% Held by Institutions

31.59%

Balance Sheet

Total Cash(mrq)

95.79M

Total Cash Per Share(mrq)

Total Debt(mrq)

13.16M

Total Debt/Equity(mrq)

11.60%

Current Ratio(mrq)

3.80%

Quick Ratio(mrq)

3.59%

Book Value Per Share(mrq)

1.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.49

Free Cash Flow(ytd)

-32.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SOPH

SOPHiA Genetics SA

SOPHiA Genetics SA Profile